HomeCNSP • NASDAQ
add
CNS Pharmaceuticals Inc
Previous close
$6.74
Day range
$6.93 - $7.18
Year range
$4.93 - $114.00
Market cap
4.45M USD
Avg Volume
14.87K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.25M | -42.20% |
Net income | -3.22M | 42.59% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -3.25M | 42.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 9.86M | 41.46% |
Total assets | 11.87M | 60.19% |
Total liabilities | 1.96M | -51.71% |
Total equity | 9.91M | — |
Shares outstanding | 620.29K | — |
Price to book | 0.39 | — |
Return on assets | -61.67% | — |
Return on capital | -70.15% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.22M | 42.59% |
Cash from operations | -2.17M | 68.03% |
Cash from investing | — | — |
Cash from financing | -91.62K | -100.75% |
Net change in cash | -2.27M | -141.33% |
Free cash flow | -886.49K | 84.96% |
About
Founded
2017
Headquarters
Website
Employees
5
